News & Perspective

(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.

(CIDRAP News) – The lead researcher of one of the controversial H5N1 avian influenza transmission studies in ferrets said today that he hopes scientists can resume work on the studies in about 2 weeks, after key groups have discussed the issues.